Clinical trial

Study of JK07 in Patients With Chronic Heart Failure

NCT06369298

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2024-03-28

PhasePHASE2

Study timeline

Study start (actual)2024-03-28Date precision: day

Registry last updated2026-05-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failure With Reduced Ejection Fractionunresolved

Heart Failure With Preserved Ejection Fractionunresolved

Interventions

JK07DRUG

PlaceboDRUG

Sponsors & collaborators

Salubris Biotherapeutics Inclead sponsor

Mapped research locations

DallasTexas, United States2 St LouisMissouri, United States2 BirminghamAlabama, United States2 HoustonTexas, United States1 BostonMassachusetts, United States1 ChicagoIllinois, United States1 Los AngelesCalifornia, United States1 BaltimoreMaryland, United States1 AtlantaGeorgia, United States1 ClevelandOhio, United States1 CincinnatiOhio, United States1 PortlandOregon, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06369298 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.